ArticleCureus2025
Human Chorionic Gonadotropin Injection to Retrieve Mature Oocytes During Laparoscopic Surgery for Ovarian Tissue Cryopreservation: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For young women with cancer facing the risk of infertility due to upcoming chemotherapy or radiotherapy, embryo cryopreservation (ECP), oocyte cryopreservation (OCP), and ovarian tissue cryopreservation (OTC) have been proposed. For some adolescent and adult patients who need immediate initiation of cancer treatment as well as prepubertal patients, only OTC is an option for fertility preservation. However, OCP is recommended for patients who can choose both OCP and OTC because the live birth rate after OTC is still insufficient. In this case, we were able to perform OCP as well as OTC with human chorionic gonadotropin (hCG) injection before surgery for a pubertal girl. The parents of a 15-year-old girl undergoing radiotherapy and chemotherapy (vincristine) after brain surgery for medulloblastoma approached our department to request fertility preservation for their daughter. Her menstruation had stopped, and maintenance chemotherapy (cisplatin, vincristine, cyclophosphamide) was scheduled one month after the current treatment ended. We informed them about the utility of each fertility preservation method and recommended OTC for the patient during her break from chemotherapy. The parents desired OCP because the pregnancy rate for OTC and ovarian tissue transplantation (OTT) was not satisfactory. With magnetic resonance imaging (MRI) showing small follicles and the resumption of menstruation in the patient, we decided to conduct follicle aspiration for OCP during surgery for OTC. Thirty-five hours before laparoscopic oophorectomy for OTC, hCG was injected. During laparoscopic surgery, all three small follicles that were visible were manually aspirated with an 18-gauge needle. Two oocytes, one mature and one degenerated, were retrieved. The mature oocyte and unilateral ovarian tissue were cryopreserved. The patient was discharged two days after OTC and returned four days later for maintenance chemotherapy. For young patients with cancer undergoing OTC, hCG administration may be an effective therapeutic option for retrieving mature oocytes during surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.